Stocks· September 09, 2026 at 05:00 PM
Authored by·Editorially reviewed
Onur Erkan YıldızFounder, Financial Engineer · CMB-licensed
Higher education in Financial Engineering and Money & Capital Markets. SPK (Turkey CMB) licence. 16 years across institutional markets, research, and quant-driven analytics.
NeutralMedium impact
AI summary
UpDoc, an enterprise-ready clinical AI company developing physician-grade agentic AI, today announced it has been selected by the Advanced Research Projects Agency for Health (ARPA-H) as a lead performer in the Agentic AI-Enabled Cardiovascular Care Transformation (ADVOCATE) program, with an award of up to $9.2 million. Microsoft, OpenAI and NVIDIA join supporting the UpDoc-led team.
Affected symbols
AI commentary is generated from public news feeds and is not investment advice.
Related coverage
StocksMedium impactNeutral35m
Veteran Bank Revamps Qualcomm Price Target After Amazon AI Chip Deal
via Yahoo Finance
AMZN
StocksMedium impactNeutral35m
SpaceX Built AI Data Centers So Fast, Some Ran Without Backup Power for Months. Now It Faces a $920 Million Deadline.
via Yahoo Finance
GOOGL
StocksMedium impactNeutral38m
Zankore Raises $3.1 Billion With Nvidia Sharing the Credit Risk
via Yahoo Finance
NVDA
StocksMedium impactNeutral39m
AT&T CEO John Stankey on $1,999 Apple iPhone Duo: 'This is not new'
via Yahoo Finance
AAPL